Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Artiva Biotherapeutics, Inc. | 10%+ Owner | Common Stock | 3.31M | Jul 22, 2024 | Direct | ||
Artiva Biotherapeutics, Inc. | 10%+ Owner | Common Stock | 1.26M | Jul 22, 2024 | By GC Cell Corporation | ||
Artiva Biotherapeutics, Inc. | 10%+ Owner | Series A Preferred Stock | 0 | Jul 22, 2024 | By GC Cell Corporation | ||
Artiva Biotherapeutics, Inc. | 10%+ Owner | Series A Preferred Stock | 0 | Jul 22, 2024 | Direct | ||
Artiva Biotherapeutics, Inc. | 10%+ Owner | Series B Preferred Stock | 0 | Jul 22, 2024 | By GC Cell Corporation | ||
Artiva Biotherapeutics, Inc. | 10%+ Owner | Series B Preferred Stock | 0 | Jul 22, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ARTV | Artiva Biotherapeutics, Inc. | Jul 22, 2024 | 12 | $30.6M | 4 | Jul 22, 2024 | 10%+ Owner |
ARTV | Artiva Biotherapeutics, Inc. | Jul 18, 2024 | 0 | $0 | 3 | Jul 18, 2024 | 10%+ Owner |